Treatment of Influenza in Children
Weight-Based Dosing Algorithm
- The American Academy of Pediatrics recommends oseltamivir administration at a weight-based dose: 30 mg twice daily for children ≤15 kg, 45 mg twice daily for children >15-23 kg, given orally for 5 days, ideally initiated within 48 hours of symptom onset 1, 2, 3
- For children ≤15 kg, the recommended dose is 30 mg (5 mL of oral suspension) twice daily for 5 days 1, 2, 3
- For children >15-23 kg, the recommended dose is 45 mg (7.5 mL of oral suspension) twice daily for 5 days 1, 2, 3
- For children >23-40 kg, the recommended dose is 60 mg (10 mL of oral suspension) twice daily for 5 days 1, 2, 3
Formulation and Administration
- Oseltamivir is available as an oral suspension at 6 mg/mL concentration, which is the preferred formulation for this age group 1, 2, 3
- If the commercially manufactured suspension is unavailable, pharmacies can compound a suspension by mixing capsule contents with simple syrup or Ora-Sweet SF to achieve 6 mg/mL concentration 1, 3
- Administer oseltamivir with food to reduce gastrointestinal side effects, which occur in approximately 10-15% of patients 2, 3
Timing of Treatment Initiation
- Treatment must be started within 48 hours of symptom onset for maximum benefit 1, 3
- Even when initiated after 48 hours, treatment should still be considered in children with moderate-to-severe or progressive disease 1
Indications for Treatment
- Treat all 1-year-olds with confirmed or suspected influenza who present within 48 hours of symptom onset 1, 4, 5
- Children under 2 years are at increased risk for hospitalization and complications from influenza 1
Safety Profile
- Oseltamivir is FDA-approved for treatment in children as young as 2 weeks of age 1, 3
- In infants and young children, the safety profile is similar to older children 1, 3
Critical Pitfalls to Avoid
- Do not round up to the next weight category – a child weighing exactly 15 kg should receive 30 mg, not 45 mg 2
- Do not delay treatment waiting for laboratory confirmation in high-risk patients (children <2 years) during influenza season 1, 3
- Ensure accurate volume measurement using a calibrated oral dosing device, not household spoons 2
- Complete the full 5-day course even if symptoms improve earlier 1, 3
Special Considerations
- For children with renal impairment (creatinine clearance 10-30 mL/min), reduce the dose to 30 mg once daily instead of twice daily 3
- Oseltamivir can be used safely in children with common comorbidities including asthma, chronic pulmonary disease, cardiovascular disease, and diabetes – these are not contraindications 3